Landing-page specialist Unbounce is buying attribution and analytics software provider LeadsRx in a bid to help its SMB clients increase the quality and volume of their conversions. Terms of the deal, announced on Wednesday, were not disclosed, but Unbounce is a much larger company. Unbounce has more than 250 employees, while LeadsRx has a headcount… Continue reading »
The post Unbounce Double-Clicks On Attribution With LeadsRx Acquisition appeared first on AdExchanger.
More Stories
By the Book: How ‘The Fugitive’ Director and an Investigative Journalist Collaborated on 2024’s Timeliest Thriller
The Best Holiday Ads of 2024
The Year in Ratings: How the Major News Outlets Performed in 2024